3 unknown. .
Follow Yi Han: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency Gene Polymorphism, Edoxaban | Unknown | Yi Han | 220 | 2024-05-01 | 2024-05-29 | |
| Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency Heart Failure, Levosimendan | Unknown | Yi Han | 1600 | 2023-11-16 | 2024-01-16 | |
| Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure Heart Failure, Levosimendan | Unknown | Yi Han | 352 | 2023-05-30 | 2023-06-22 |
Heart Failure (2) · Renal Insufficiency (2)
China (3)